Recent developments

at Tullis and our portfolio companies

News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

December

1

electroCore Announces Selection of gammaCore for National Institute on Drug Abuse (NIDA)-Sponsored Study in Opioid Use Disorders

Randomized controlled study run by Dr. Douglas Bremner at Emory University in collaboration with the Georgia Institute of Technology and...

16

Exagen and GSK Partner for Fourth Straight Year

Continued collaboration drives greater awareness of challenges facing lupus diagnosis and management SAN DIEGO, Nov....

12

electroCore Announces Third Quarter Financial Results

Revenue growth of 44% over the second quarter of 2020 and 58% over the third quarter of 2019...

10

Exagen Inc. Reports Third Quarter 2020 Results

Record Adopters with 99% Stickiness and 14 Million In-Network Lives Added for AVISE® Testing...

5

ATEC Reports Third Quarter 2020 Financial Results And Recent Corporate Highlights

U.S. Revenue Grows 43% Eighth Consecutive Quarter of Double-Digit Revenue Growth CARLSBAD, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) — Alphatec...

2

Exagen Inc. Announces Study to Evaluate Emergence of Autoimmune Diseases After COVID-19 Infection

Collaboration with Boston-based Brigham and Women’s Hospital to study effects of COVID-19 on the...

22

TriSalus Life Sciences Appoints Trevor McCaw as Chief Commercial Officer

Experienced commercial leader solidifies Company’s management team as it integrates novel therapies with innovative...

21

electroCore, Inc. Appoints Business Development Leader and US Navy Veteran Sylvester Steele as VP and General Manager of Government Channels Business Unit

Newly created position to focus on driving growth within the Veterans Administration, Department of...

19

ATEC Extends InVictus MIS Platform With Commercial Release Of InVictus MIS Tower

Elevates MIS posterior fixation optionality Robust instrumentation designed to treat more complex pathologies less invasively CARLSBAD, Calif., Oct. 19,...

16

ATEC Announces Closing Of Public Stock Offering And Full Exercise Of Underwriters’ Option To Purchase Additional Stock

Total gross proceeds of approximately $115.0 million, before underwriting discounts and commissions and estimated offering...

14

ATEC Announces Pricing Of Public Offering Of Common Stock

11,428,570 shares of common stock at a public offering price of $8.75 per share Alphatec...

13

ATEC Announces Proposed Public Offering Of Common Stock

CARLSBAD, Calif., Oct. 13, 2020 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative...

Recent developments

News

December

1

electroCore Announces Selection of gammaCore for National Institute on Drug Abuse (NIDA)-Sponsored Study in Opioid Use Disorders

November

16

Exagen and GSK Partner for Fourth Straight Year

November

12

electroCore Announces Third Quarter Financial Results

November

10

Exagen Inc. Reports Third Quarter 2020 Results

November

5

ATEC Reports Third Quarter 2020 Financial Results And Recent Corporate Highlights

November

2

Exagen Inc. Announces Study to Evaluate Emergence of Autoimmune Diseases After COVID-19 Infection

October

22

TriSalus Life Sciences Appoints Trevor McCaw as Chief Commercial Officer

October

21

electroCore, Inc. Appoints Business Development Leader and US Navy Veteran Sylvester Steele as VP and General Manager of Government Channels Business Unit

October

19

ATEC Extends InVictus MIS Platform With Commercial Release Of InVictus MIS Tower

October

16

ATEC Announces Closing Of Public Stock Offering And Full Exercise Of Underwriters’ Option To Purchase Additional Stock

October

14

ATEC Announces Pricing Of Public Offering Of Common Stock

October

13

ATEC Announces Proposed Public Offering Of Common Stock